Financials
- Market Capitalization 1.85 B
- Employee 108
- Founded 2004
- CEO Silviu Itescu
- Website www.mesoblast.com
- Headquarter Australia
- FIGI BBG000QD6LZ1
- Industry 生物工学
総売上高
当期純利益
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1990 | URGN UroGen Pharma Ltd. - Ordinary Shares | 38.28 USD | +3.94% | -11.47% | -9.63% | +101.47% | 1.87 B USD | ||
| 1994 | XNCR Xencor, Inc. - Common Stock | 25.04 USD | +1.66% | -2.80% | +1.34% | +79.50% | 1.86 B USD | ||
| 2005 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.93 USD | -1.97% | -6.51% | -19.19% | +35.39% | 1.84 B USD | ||
| 2006 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 17.44 USD | -2.30% | -1.13% | -15.13% | -19.18% | 1.84 B USD |